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Abstract  23 
Background  24 
There is increasing evidence that an increased BMI is associated with increased 25 
complications after surgery for colorectal cancer (CRC). However, the basis of this 26 
relationship is not clear. Since men and women have different fat distribution, with men more 27 
likely to have excess visceral fat in BMI defined obesity, there may be a sex difference in the 28 
surgical site infection (SSIs) rate in the obese. Therefore, the aim of this study was to 29 
examine the relationship between sex, BMI, clinic-pathological characteristics and the 30 
development of postoperative infective complications after surgery for CRC and to establish 31 
whether there were gender differences in complication following surgery for CRC.  32 
Design  33 
Data were recorded prospectively for patients undergoing potentially curative surgery for 34 
CRC in a single centre between 1997 and 2016. Patient characteristics were recorded and 35 
complications were classified as either infective or non-infective. The relationship between 36 
sex, BMI, associated clinicopathological characteristics and presences of complications were 37 
examined by Chi-square test for linear association and multivariate binary logistic regression 38 
model. 39 
Results 40 
A total of 1039 patients were included. There were significant differences in the presence of 41 
complications between male and female (p≤0.001), the rate of complication was higher in 42 
obese male (44%); in particular SSIs, wound infection and anastomotic leak (p≤0.05).  The 43 
rate of surgical site infection was 12% in male patients with normal BMI compared with 26% 44 
in those with a BMI ≥30 (p≤0.001), while the rate of SSIs in female patients was 10% in 45 
 3 
those with normal BMI and those with a BMI ≥30.  In males, BMI remained significantly 46 
associated with SSI on multivariate analysis [(OR =1.42, 95% CI 1.13-1.78) P=0,002]. 47 
Conclusions 48 
Obesity prior to surgery for CRC increases the risk of infective complications in both male 49 
and female. Increased BMI in male patients was associated greater risk of SSIs and wound 50 
infection compared to female patients. Male obese patients should be considered at high risk 51 
of developing post-operative infective complications. 52 
 53 
 54 
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 56 
1-Introduction: 57 
 58 
The prevalence of obesity is increasing globally and has become a major public health 59 
concern.  In the United Kingdom, the prevalence of obesity has increased dramatically over 60 
the past few years to such an extent that approximately 30% of the population had a body 61 
mass index (BMI) over 30. The UK now has the highest rate of obesity in Western Europe, 62 
according to the Organisation for Economic Co-operation and Development (OECD) (1) 63 
Obesity has been associated with increased risk of several chronic diseases, such as high 64 
blood pressure, chronic heart disease, renal disease, type 2- diabetes and many forms of 65 
cancer including colorectal cancer (2). Indeed, a meta-analysis with 70,000 cases reported 66 
that for each 2 kg/m2 increase in BMI there was a 7% higher risk of colorectal cancer (3). 67 
This association was stronger in males than females, and sex may play a major role in disease 68 
progress and outcomes. In addition to increased risk, a large prospective study, with 900,000 69 
subjects, reported an association between BMI and risk of death from colorectal cancer (4) 70 
Moreover, studies comparing the outcome for the two sexes have reported improved long 71 
term survival of women with colorectal cancer which is not explained by any substantial 72 
differences in extent of disease or treatment delivered (5,6). However, whether women and 73 
men show differences in short term outcomes is not well described. 74 
Despite major advances in surgical procedures, surgical morbidity after colorectal cancer 75 
resection remains a significant problem, with infectious complications, particularly surgical 76 
site infections (SSIs), the most frequent, accounting for 30-40% of all complications (8). The 77 
National Nosocomial Infection System (NNIS) of the US Center for Disease Control and 78 
Prevention (CDC) has classified surgical site infection into superficial wound infection and 79 
deep organ/space infection, including anastomotic leak and abscess (9). It has been reported 80 
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that these complications contribute to a high rate of re-operation, increased length of hospital 81 
stay, higher hospital costs (10) and early mortality (11). 82 
 There is increasing evidence that obesity at the time of surgery is associated with increased 83 
risk of postoperative infective complications in patients with colorectal cancer. For example, 84 
it has been recently reported that patients with high BMI are at increased risk for surgical site 85 
infection following surgery for colorectal cancer, independent of other potentially 86 
confounding factors (7). An implication of this systematic review was that since, men and 87 
women have different fat distribution with men more likely to have excess visceral fat in 88 
BMI defined obesity, there may be a sex difference in the surgical site infection rate in the 89 
obese.  However, to our knowledge this relationship has not been examined. 90 
An understanding of the association between sex, obesity, and the post-operative systemic 91 
inflammatory response and complications of colorectal cancer surgery is important to 92 
evaluate the risks associated with colorectal cancer surgery. The aim of the present study, 93 
therefore, was to examine the relationship between sex, BMI, pre-and post-operative systemic 94 
inflammatory response and development of postoperative infective complications following 95 
surgery for colorectal cancer. 96 
 97 
98 
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 99 
2-Methods 100 
Anonymised data was prospectively collected for patients who underwent elective, 101 
potentially curative surgery for colorectal cancer in a single centre between January 1997 and 102 
February 2016. Those who underwent an emergency procedure were excluded. Recorded 103 
information included demographics, tumour site, TNM stage, surgical approach, whether 104 
neoadjuvant or adjuvant treatment was given, and the presence and type of complications. 105 
BMI was calculated from height and weight measured at the preoperative assessment visit 106 
prior to surgery and BMI categorised according to the WHO cut-offs (normal weight 18.5- 107 
24.9, overweight 25- 29.9, obese 30-34.9, morbidly obese ≥35).  A small number of patients 108 
who were classified as underweight (4% of all patients) were excluded from the analysis. 109 
 The preoperative systemic inflammatory response was assessed using the preoperative 110 
modified Glasgow Prognostic Score (mGPS), calculated from preoperative serum C-reactive 111 
protein (CRP) and albumin. Patients with a CRP ≤10mg/L were allocated a score of 0, a 112 
CRP > 10mg/L a score of 1, and a CRP >10mg/L and albumin <35g/L a score of 2.  The 113 
postoperative systemic inflammatory response was assessed using the postoperative Glasgow 114 
Prognostic Score (post-op GPS). Patients with postoperative CRP concentration ≤150 mg/L 115 
were allocated a score of 0, a CRP concentration > 150 mg/L a score of 1, and CRP 150 116 
mg/L and albumin <25 g/L a score of 2.  117 
Patients were assessed for both infective and non-infective complications. Infective 118 
complications included; respiratory tract infection, urinary tract infection, or any surgical site 119 
infection. Non-infective complications included; ileus, acute coronary syndrome, acute 120 
myocardial infarction, pulmonary embolism and arrhythmias. 121 
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Surgical site infection was defined as the presence of superficial wound infection or a deep 122 
organ/space infection (including intra-abdominal abscess and anastomotic leakage). A wound 123 
infection included the presence of pus that discharged spontaneously or required drainage; an 124 
intra-abdominal abscess was confirmed by imaging and required either conservative therapy 125 
with antibiotics or drainage; an anastomotic leak was defined as a fistula to the bowel 126 
anastomosis that was confirmed radiologically or diagnosed at relaparotomy. Any 127 
uncertainties were addressed by review of electronic and/or physical case notes. The study 128 
was approved by the West of Scotland Research Ethics Committee, Glasgow. 129 
Statistical Analysis 130 
Categorical data regarding patient and disease characteristics were examined and compared 131 
by Chi-square test and Chi square test for linear association where appropriate. P values 132 
<0.05 were considered statistically significant. Surgical site infection was analysed using 133 
univariate and multivariate binary logistic regression model.  Those variables associated to a 134 
degree of p<0.1 were entered into a backward conditional multivariate model.  Those 135 
variables found to be significantly associated with surgical site infection were entered into a 136 
multivariate model. Statistical analyses were performed using IBM SPSS version 22 for 137 
Windows (Chicago, IL, USA). 138 
 139 
140 
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3-Results: 142 
 143 
 A total of 1039 patients were included having undergone potentially curative surgery for 144 
colorectal cancer (587 were male and 452 were female). 145 
 146 
3.1 Gender, clinicopathological characteristics and post-operative complications. 147 
When the patient’s demographic, pathological, and clinical characteristics were compared 148 
between male and female (Table 2), there was a significant difference in tumour site 149 
(p≤0.05), post -operative GPS day 3 (p≤0.05) and operative time (p≤0.05). There were also 150 
significant differences in the presence of complications between male and female (p≤0.001) 151 
with male having higher rate of complication (44%), in particular infective complications 152 
(p≤0.05).  153 
3.2 The distribution of the clinicopathological characteristics and post-operative 154 
complications in male and female based on BMI.  155 
In Table 2, male patients were classified by BMI, 33% were normal weight, 39% overweight, 156 
19% were obese and 9% were morbidly obese. When the distribution of the 157 
clinicopathological characteristics in male patients were compared according to BMI, there 158 
was a significant association between BMI and age (p≤0.05) smoking (p≤0.001), year of 159 
surgery (p≤0.05), pre-operative mGPS (p≤0.05), NLR (p≤0.001) and neoadjuvant therapy 160 
(p≤0.05).   161 
Among the male patients, 241(44%) experienced complications. Of these patients 160 (29%) 162 
had infective complications, where 104 (19%) had non-infective complications. When 163 
complications were compared across BMI categories, there was a significant association of 164 
BMI with the occurrence of surgical site infection (p<0.001) and wound infection (p<0.001).  165 
 9 
The rate of surgical site infection was 12% in male patients with normal BMI compared with   166 
26% in those with a BMI ≥30 (p≤0.001). wound infection was 7% with normal BMI 167 
compared with 20 % in those with a BMI ≥30 (p≤0.001). 168 
In Table 4, female patients were classified by BMI, 41% were normal weight, 29% 169 
overweight, 17% were obese and 13% were morbidly obese. When the distribution of the 170 
clinicopathological characteristics in female patients were compared according to BMI, there 171 
was a significant association between BMI and age (p≤0.001), NLR (p≤0.001), ASA grade 172 
(p≤0.05), Laprascopic (p≤0.05), Post-operative GPS day 4 (p≤0.001).           173 
Infective complication in female patients, was significantly associated with higher BMI 174 
(p<0.05); in particular wound infections (p<0.001). Wound infection was 6 % in female 175 
patients with normal BMI compared with 8% in those with a BMI ≥30 (p=0.003). The rate of 176 
surgical site infection in female patients was 10% with normal BMI and same in those with a 177 
BMI ≥30 (p=0.054). There was no significant association between BMI and non-infective 178 
complications in both male and female. 179 
3.3 Surgical site infection, BMI and confounding factors  180 
Among the male patients (Table 3), univariate analysis of surgical site infection, there was a  181 
significant association with BMI and age. BMI remained significantly associated with 182 
surgical site infection on multivariate analysis [(OR =1.42, 95% CI 1.13-1.78) P=0,002]. In 183 
female patients (Table 5), univariate analysis of surgical site infection detected a significant 184 
association with BMI (P=0.055), NLR>5(P=0.004), Laprascopic(0.006), post-operative day 4 185 
GPS (P≤0.001). ).  On multivariate analysis of these significant variables, the inflammatory 186 
markers; NLR>5 [(OR=2.92, 95% CI 1.09-7.81) P=0.033] and post-operative day 4 GPS 187 
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(OR=2.22, 95% CI 1.47-3.34) P≤0.001] remained independently associated with surgical site 188 
infection.  189 
190 
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Discussion: 191 
 192 
 193 
In the present study, there was a gender difference in the occurrence of complications 194 
following surgery for colorectal cancer.  To our knowledge few studies address obesity and 195 
gender differences in complication. In this study, postoperative infective complications 196 
including surgical site infection and wound infection were higher in obese men, while the rate 197 
of surgical site infections in female patients was same in those with normal BMI and those 198 
with a BMI ≥30. In addition, BMI in male patients was significantly associated with surgical 199 
site infection independent of other confounding factors. Therefore, in male patients 200 
undergoing surgery for colorectal cancer obesity should be considered at high risk of 201 
developing post-operative infective complications.  202 
The basis of the relationship between obesity and postoperative infection is not clear. This 203 
association could be in part accounted for by the magnitude of the post-operative systemic 204 
inflammatory response. It is of interest that obesity as well as cancer has a clear, but not yet 205 
precisely defined, effect on the immune function through a variety of immune mediators, 206 
including abnormal production of cytokines and acute-phase proteins (12). The excess 207 
adiposity and secretion of free fatty acids from the adipose tissue in obese patients, leads to 208 
dysregulation of adipose tissue-derived secretory factors, such as adipokines. These can 209 
trigger chronic low-grade inflammation and interact with a range of processes in metabolic 210 
tissues, including skeletal muscle and liver (12). Furthermore, the inflammatory state may 211 
play a role in the pathogenesis of many obesity related conditions, part of the metabolic 212 
syndrome, such as hyperglycaemia, insulin resistance and diabetes, and may therefore 213 
influence colorectal surgical outcomes.  214 
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Since abdominal obesity is predominant in males, the present result would indicate that the 215 
association was probably not due to differences in sex hormones but merely due to the fact 216 
that men had more fat inside the abdominal wall, which may result in more difficult 217 
resections, the need for longer incisions (13) and the need for long operative time. In 218 
addition, adiposity may affect the tissue concentrations of preoperative antibiotics (14). 219 
Furthermore, abdominal obesity is associated with metabolic abnormalities such as 220 
hyperinsulinemia and insulin resistance, as well as the release of insulin like growth factors, 221 
that are known to contribute to the proliferation and progression of malignant colonic cells 222 
and associated with poor operative outcome (15).  Finally, the presence of excess visceral fat 223 
tissue in obese patients, with decreased oxygen tension and circulation, leads to increased 224 
susceptibility to infections and impaired wound healing (16). However, prior to surgery for 225 
colorectal cancer, the potential for reducing the level of obesity in the male patient is limited. 226 
Therefore, surgical management of these patients should take into account the increased risk 227 
for developing surgical site infection.   228 
An important strength of this study is its relative large size in a detailed cohort of patients 229 
with colorectal cancer.  Limitations include that the data have been retrospectively analysed. 230 
In addition, a measurement of obesity by BMI does not give insight in to the body 231 
composition changes that may be important in the development of surgical site infection. 232 
More detailed analysis of body composition including visceral fat and skeletal muscle mass 233 
assessment may provide more specific markers for post-operative complications. 234 
In summary, the results of the present study indicate that male patients with BMI defined 235 
morbid obesity are of increased risk of surgical site infection and wound infection after 236 
surgery for colorectal cancer.  This should be taken into into consideration when developing 237 
post-operative management plans. Further investigation of the association between sex, BMI, 238 
 13 
body composition and the development of post-operative infective complications is 239 
warranted. 240 
241 
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  Table 1. Clinico-pathological characteristics, systemic inflammation, and complications following surgery for colorectal cancer 
(male/female, n=1039). 
Characteristics  Male 
n          587 
(%)     (56) 
Female 
452 
(44) 
P (value) 
Age (<65/65-74/>74) 206/233/148 
(35/40/25) 
168/152/132 
(37/34/29) 
0.698 
BMI (18.5-24.99/ 25-29.99/30-34.9/ ≥35) 194/228/114/51 
(33/39/19/9) 
183/132/79/58 
(41/29/17/13) 
0.859 
Smoking (no/yes)* 418/83 
(83/17) 
319/55 
(85/15) 
0.455 
Year of surgery (1997-2007/2008-2016) 183/403 
(31/69) 
140/312 
(31/69) 
0.930 
TNM stage (I/II/III/IIII) 127/230/190/22 
(23/40/33/4) 
89/192/144/13 
(20/44/33/3) 
0.954 
Tumour site (colon/ rectum) 345/239 
(59/41) 
299/151 
(66/34) 
0.015 
ASA grade (1/2/3/4) 107/253/171/22 
(19/46/31/4) 
87/191/141/11 
(20/44/33/3) 
0.713 
Preop mGPS (0/1/2) 418/67/59 
(77/12/11) 
320/60/42 
(76/14/10) 
0.978 
NLR > 5 (no, yes) 427/81 
(84/16) 
345/55 
(86/14) 
0.358 
Laparoscopic (no/yes) 244/141 
(63/37) 
184/107 
(63/37) 
0.969 
Operative time > 4 h (no/yes)* 213/126 
(63/37) 
191/74 
(72/28) 
0.017 
POD3 GPS (0/1/2) 225/96/80 
(56/24/20) 
216/46/59 
(67/14/18) 
0.032 
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POD4 GPS (0/1/2) 265/61/61 
(68/16/16) 
231/26/44 
(77/9/15) 
0.099 
Neoadjuvant therapy (no/yes) 493/71 
(87/13) 
381/57 
(87/13) 
0.842 
Adjuvant therapy (no/yes) 364/135 
(73/27) 
284/110 
(72/28) 
0.774 
Any complication (no/yes) 303/241 
(56/44) 
281/145 
(66/34) 
≤0.001 
Non-infective complication(no/yes) 440/104 
(81/19) 
363/63 
(85/15) 
0.076 
Infective  complication (no/yes) 384/160 
(71/29) 
329/97 
(77/23) 
0.020 
Surgical site infection  (no/yes) 436/104 
(81/19) 
368/57 
(87/13) 
0.016 
Wound infection (no/yes) 477/67 
(88/12) 
392/34 
(92/8) 
0.028 
Anastomotic leak (no/yes) 511/33 
(94/6) 
412/14 
(98/3) 
0.046 
Chi square test for linear association. Data are expressed n (%)  
Pre-op mGPS: preoperative modified Glasgow prognostic score 
Pre-op NLR: preoperative neutrophil/lymphocyte ratio 
POD: Post Operative Day 
* Missing value  
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Table 2.  The relationship between BMI, clinicopathological characteristic and postoperative complications in male patients with 
colorectal cancer (n=587). 
Characteristics     Total Patients 
 
n 
           (%) 
BMI P (value) 
18.5-24.99 
194 
(33) 
25-29.99 
228 
(39) 
30-34.99 
114 
(19) 
≥35 
51 
(9) 
Age ( 65,65-74, >75) 206/233/148 
(35/40/25) 
66/63/65 
(34/33/33) 
82/88/58 
(36/3925) 
36/60/18/114 
(32/53/16) 
22/22/7 
(43/43/14) 
0.010 
Year of surgery (1997-2007/2008-2016) 183/204  
(31/69) 
66/127 
(34/66) 
83/145 
(36/64) 
22/92 
(19/81) 
12/39 
(23/77) 
0.009 
TNM stage (I/II/III/IIII) 127/230/190/22 
(23/40/33/4) 
37/90//53/7 
(20/48/28/4) 
45/83/85/8 
(20/38/39/4) 
32/38/35/6 
(29/34/31/5) 
13/19/17/1 
(26/38/34/2) 
0.672 
Smoking (no/yes) 418/83 
(83/17) 
128/38 
(77/23) 
161/33 
(83/17) 
92/12 
(89/11) 
37/0 
(100/0) 
<0.001 
Tumour site (colon/ rectum) 345/239 
(59/41) 
109/84 
(57/43) 
136/91 
(60/40) 
69/45 
(60/40) 
31/19 
(62/38) 
0.386 
Preop mGPS(0/1/2) 418/67/59  
(77/12/11)        
119/29/27 
(68/17/15) 
178/18/20 
(82/8/10) 
86/14/6 
(81/13/6) 
35/6/6 
(74/13/13) 
0.040 
NLR > 5 (no, yes) 427/81 
(84/16) 
 
126/39 
(76/24) 
165/27 
(86/14) 
94/12 
(89/11) 
42/3 
(93/7) 
<0.001 
ASA grade (1/2/3/4)  107/253/171/22 
(19/46/31/4) 
34/82/61/7 
(19/45/33/4) 
54/90/61/8 
(25/42/29/4) 
13/59/29/6 
(12/55/27/6) 
6/22/20/1 
(12/45/41/2) 
0.393 
Laparoscopic (no/yes)*  244/141 
(63/37) 
82/35 
(70/30) 
81/58 
(58/42) 
56/35 
(62/38) 
25/13 
(66/34) 
0.379 
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Operative time > 4 h (no/yes)* 213/126 
(63/37) 
64/38 
(63/37) 
75/50 
(60/40) 
54/28 
(66/34) 
20/10 
(67/33) 
0.561 
PoGPS-D3(0/1/2) 225/96/80 
(56/24/20) 
 
84/16/35 
(62/12/26) 
88/35/22 
(61/24/15) 
40/30/14 
(48/36/17) 
13/15/9 
(35/41/24) 
0.125 
PoGPS-D4(0/1/2) 265/61/61 
(68/16/16) 
85/13/25 
(69/11/20) 
110/17/20 
(75/12/14) 
47/21/11 
(59/27/14) 
23/10/5 
(61/26/13) 
0.730 
Neoadjuvant therapy (no/yes) 493/71 
(87/13) 
151/34 
(82/18) 
195/25 
(89/11) 
103/8 
(93/7) 
44/4 
(92/8) 
0.005 
Adjuvant therapy (no/yes) 364/135 
(73/27) 
130/38 
(77/23) 
141/59 
(70/30) 
63/25 
(72/28) 
30/13 
(70/30) 
0.216 
Any complication (no/yes) 303/241 
(56/44) 
103/77 
(57/43) 
121/88 
(56/42) 
55/53 
(51/49) 
24/23 
(51/49) 
0.258 
Non-infective complication(no/yes) 440/104 
(81/19) 
148/32 
(82/18) 
170/39 
(81/19) 
85/23 
(79/21) 
37/10 
(79/21) 
0428. 
Infective complication(no/yes) 384/160 
(71/29) 
131/49 
(73/27) 
149/60 
(71/29) 
73/35 
(68/32) 
31/16 
(66/34) 
0.246 
Surgical site infection (no/yes) 436/104 
(81/19) 
157/22 
(88/12) 
167/41 
(80/20) 
79/28 
(74/26) 
33/13 
(72/28) 
<0.001 
Wound infection (no/yes) 477/67 
(88/12) 
168/12 
(93/7) 
187/22 
(90/10) 
86/22 
(8/20) 
36/11 
(77/23) 
<0.001 
Anastomotic leak (no/yes) 511/33 
(94/6) 
173/7 
(96/4) 
192/17 
(92/8) 
103/5 
(95/5) 
43/4 
(92/8) 
0.370 
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Table 3. Relationship between surgical site infection, BMI and associated clinic-pathological characteristics in male patients with 
colorectal cancer. (n=587). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Binary logistic regression model 
 
 
 
 
Variable Univariate  
OR (95% CI) 
P value Multivariate 
OR (95% CI) 
P value 
BMI  1.45(1.16-1.81) ≤0.001 1.42(1.13-1.78)   0.002 
Age  0.76(0.57-1.00) 0.055 -   0.107 
Smoking 0.98(0.50-1.93) 0.959 - - 
Year of surgery 1.22(0.76-1.94) 0.413 - - 
Neoadjuvant therapy  0.165(0.90-3.01) 0.104 - - 
Pre-op mGPS 1.03(0.75-1.42) 0.851 - - 
NLR>5 0.90(0.48-1.69) 0.747 - - 
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Table 4.  The relationship between BMI, clinicopathological characteristic and postoperative complications in female patients with 
colorectal cancer (n=452). 
Characteristics  Total Patients 
 
n 
(%) 
BMI P (value) 
18.5-24.99 
183 
(41%) 
25-29.99 
132 
(29%) 
30-34.99 
79 
(17%) 
≥35 
58 
(13%) 
Age (65,65-74, >75) 168/152/132 
(37/34/29) 
58/60/65 
(32/33/35) 
49/49/34 
(37/37/26) 
30/29/20 
(38/37/25) 
31/14/13 
(63/24/22) 
0.004 
Year of surgery (1997-2007/2008-2016) 140/312 
(31/69) 
73/110 
(40/60) 
42/90 
(32/68) 
21/58 
(27/74) 
4/54 
(7/93) 
<0.001 
Smoking (no/yes) 
 
319/55 
(85/15) 
121/19 
(86/14) 
93/23 
(80/20) 
57/8 
(88/12) 
48/5 
(91/9) 
0.441 
TNM stage (I/II/III/IIII) 89/192/144/13 
(20/44/33/3) 
29/95/51/4 
(17/53/29/2) 
29/40/52/4 
(23/32/42/3) 
19/32/25/1 
(25/42/32/1) 
12/25/16/4 
(21/44/28/7) 
0.952 
Tumour site (colon/ rectum) 229/151 
(66/34) 
120/63 
(66/34) 
87/44 
(66/34) 
52/26 
(67/33) 
40/18 
(69/31) 
0.655 
Preop mGPS (0/1/2) 320/60/42 
(76/14/10) 
129/21/23 
(75/12/13) 
95/17/12 
(77/14/10) 
56/14/3 
(77/19/4) 
40/8/4 
(77/15/8) 
0.239 
NLR > 5 (no, yes) 345/55 
(86/14) 
127/32 
(80/20) 
106/13 
(89/11) 
62/7 
(90/10) 
50/33 
(94/6) 
0.004 
ASA grade (1/2/3/4)  87/191/141/11 
(20/44/33/3) 
46/67/54/5 
(27/39/31/3) 
25/60/40/1 
(20/48/32/1) 
8/38/25/4 
(11/51/33/5) 
8/26/22/1 
(14/46/39/2) 
0.033 
Laparoscopic (no/yes)*  184/107 
(63/37) 
77/28 
(73/27) 
48/35 
(58/42) 
32/23 
(58/42) 
27/21 
(56/44) 
0.025 
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Operative time > 4 h (no/yes)* 
 
191/74 
(72/28) 
70/19 
(79/21) 
56/24 
(70/30) 
36/14 
(72/28) 
29/17 
(63/37) 
0.074 
PoGPS-D3(0/1/2) 216/46/59 
(67/14/18) 
86/10/25 
(71/8/21) 
66/15/12 
(71/16/13) 
36/9/12 
(63/16/21) 
28/12/10 
(56/24/20) 
0.221 
PoGPS-D4(0/1/2) 231/26/44 
(77/9/15) 
87/4/16 
(81/4/15) 
80/7/9 
(83/7/9) 
42/4/8 
(78/7/15) 
22/11/11 
(50/25/25) 
0.006 
Neoadjuvant therapy (no/yes) 381/57 
(87/13) 
150/30 
(83/17) 
110/15 
(88/12) 
70/7 
(91/9) 
51/5 
(91/9) 
0.055 
Adjuvant therapy (no/yes) 284/110 
(72/28) 
130/34 
(79/21) 
71/45 
(61/39) 
52/16 
(76/24) 
31/15 
(67/33) 
0.152 
Any complication (no/yes) 281/145 
(66/34) 
119/53 
(69/31) 
84/43 
(66/34) 
49/25 
(66/34) 
29/24 
(55/45) 
0.089 
Non-infective complication(no/yes) 363/63 
(85/15) 
148/24 
(86/14) 
104/23 
(82/18) 
64/10 
(86/14) 
47/6 
(89/11) 
0.676 
Infective complication(no/yes) 329/97 
(77/23) 
138/34 
(80/20) 
102/25 
(80/20) 
56/18 
(76/24) 
33/20 
(62/38) 
0.014 
Surgical site infection  (no/yes) 368/57 
(86/14) 
154/18 
(90/10) 
108/19 
(85/15) 
66/7 
(90/10) 
40/13 
(75/25) 
0.054 
Wound infection (no/yes) 392/34 
(92/8) 
162/10 
(94/6) 
120/7 
(94/6) 
68/6 
(92/8) 
42/11 
(79/21) 
0.003 
Anastomotic leak (no/yes) 412/14 
(98/3) 
167/5 
(97/5) 
122/5 
(96/4) 
73/1 
(99/1) 
50/3 
(94/6) 
0.649 
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Table 5. Relationship between surgical site infection, BMI and associated clinic-pathological characteristics in female patients with 
colorectal cancer (n=452). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Variable Univariate  
OR (95% CI) 
P value Multivariate 
OR (95% CI) 
P value 
BMI 1.29 (0.99-1.67) 0.055 - 0.274 
Age 0.79 (0.55-1.11) 0.180 - - 
Year of surgery 1.72(0.89-3.31) 0.105 - - 
ASA grade 1.01(0.70-1.46) 0.944 - - 
NLR>5 2.79(1.39-5.61) 0.004 2.92(1.09-7.81) 0.033 
Laparoscopic 0.32(0.14-0.72) 0.006 - 0.105 
POD 4 GPS 2.03(1.42-2.92) ≤0.001 2.22(1.47-3.34) <0.001 
